Human papillomavirus status in head and neck cancer: The ethics of disclosure

Cancer

Volumn 116, Issue 18, 2010, Pages 4221-4226

  Shuman, Andrew G ^a   Wolf, Gregory T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Disclosure; Head and neck cancer; Human papillomavirus; Oropharynx; Patient autonomy

Indexed keywords

WART VIRUS VACCINE;

CLINICAL PROTOCOL; CONDYLOMA ACUMINATUM; HEAD AND NECK CANCER; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL ETHICS; NOTE; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS; ETHICS; FEMALE; HEAD AND NECK TUMOR; PAPILLOMAVIRUS INFECTION; PROGNOSIS; PSYCHOLOGY; RISK; SEXUALLY TRANSMITTED DISEASES; TRANSMISSION; UTERINE CERVIX TUMOR; VACCINATION; VIROLOGY;

ETHICS, MEDICAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASMS, SQUAMOUS CELL; OTORHINOLARYNGOLOGIC NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PROGNOSIS; RISK; SEXUALLY TRANSMITTED DISEASES; TRUTH DISCLOSURE; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 77957349495     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25210     Document Type: Note

References (35)

1. Mendenhall WM, Logan HL. Human Papillomavirus and Head and Neck Cancer. Am J Clin Oncol. [published online ahead of print July 31, 2009.]
2. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944-1956.
3. Chaturvedi AK, Engels EA, Anderson WF, et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26:612-619.
4. Nasman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer. 2009;125:362-366.
5. Applebaum KM, Furniss CS, Zeka A, et al. Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst. 2007;99:1801-1810.
6. Parker M. A conversational approach to the ethics of genetic testing. In: Case Analysis in Clinical Ethics. Ashcroft R, Lucassen A, Parker M, et al. eds. New York, NY: Cambridge University Press; 2005:149-165.
7. Palka KT, Slebos RJ, Chung CH. Update on molecular diagnostic tests in head and neck cancer. Semin Oncol. 2008;35:198-210.
8. Chung YL, Lee MY, Horng CF, et al. Use of combined molecular biomarkers for prediction of clinical outcomes in locally advanced tonsillar cancers treated with chemoradiotherapy alone. Head Neck. 2009;31:9-20.
9. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008;100:407-420.
10. D'Souza G, Agrawal Y, Halpern J, et al. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009;199:1263-1269.
11. Andrews E, Shores C, Hayes DN, et al. Concurrent human papillomavirus-associated tonsillar carcinoma in 2 couples. J Infect Dis. 2009;200:882-887.
12. Rosenquist K. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Swed Dent J Suppl. 2005;(179):1-66.
13. Branson BM, Handsfield HH, Lampe MA, et al. Centers for Disease Control and Prevention (CDC). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1-17.
14. Dixon-Mueller R. The sexual ethics of HIV testing and the rights and responsibilities of partners. Stud Fam Plann. 2007;38:284-296. (Pubitemid 350238612)
15. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261-269.
16. Smith EM, Wang D, Rubenstein LM, et al. Association between p53 and human papillomavirus in head and neck cancer survival. Cancer Epidemiol Biomarkers Prev. 2008;17: 421-427. (Pubitemid 351272796)
17. Sedaghat AR, Zhang Z, Begum S, et al. Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope. 2009;119:1542-1549.
18. Lucassen A. Families and genetic testing: the case of Jane and Phyllis. In: Case Analysis in Clinical Ethics. Ashcroft R, Lucassen A, Parker M, et al. eds. New York, NY: Cambridge University Press; 2005:7-27.
19. de Wert G. Ethics of predictive DNA-testing for hereditary breast and ovarian cancer. Patient Educ Couns. 1998;35:43-52.
20. Went L. Ethical issues policy statement on Huntington's disease molecular genetics predictive test. International Huntington Association. World Federation of Neurology. J Med Genet. 1990;27:34-38.
21. Duncan RE, Delatycki MB, Collins SJ, Boyd A, Masters CL, Savulescu J. Ethical considerations in presymptomatic testing for variant CJD. J Med Ethics. 2005;31:625-630.
22. Frega A, Stentella P, De Ioris A, et al. Young women, cervical intraepithelial neoplasia and human papillomavirus: risk factors for persistence and recurrence. Cancer Lett. 2003; 196:127-134.
23. Colgrove J. The ethics and politics of compulsory HPV vaccination. N Engl J Med. 2006;355:2389-2391.
24. Field RI, Caplan AL. A proposed ethical framework for vaccine mandates: competing values and the case of HPV. Kennedy Inst Ethics J. 2008;18:111-124.
25. Balog JE. The moral justification for a compulsory human papillomavirus vaccination program. Am J Public Health. 2009;99:616-622.
26. Gendel JE. Playing games with girls' health: why it is too soon to mandate the HPV vaccine for pre-teen girls as a prerequisite to school entry. Seton Hall Law Rev. 2009;39: 265-290.
27. Harrell H. Currents in contemporary ethics: HPV vaccines, privacy, and public health. J Law Med Ethics. 2009;37:134-138.
28. Marquez-Calderon S, Lopez-Valcarcel BG, Segura A. Medical societies' recommendations for immunization with human papillomavirus vaccine and disclosure of conflicts of interests. Prev Med. 2009;48:449-453.
29. Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 2008;113(10 suppl): 3036-3046.
30. Gillison ML. Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. J Adolesc Health. 2008;43(4 suppl):S52-S60.
31. Garnett GP. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease. J Infect Dis. 2005;191(suppl 1):S97-S106.
32. de Melo-Martin I. The promise of the human papillomavirus vaccine does not confer immunity against ethical reflection. Oncologist. 2006;11:393-396.
33. United States Food and Drug Association. FDA approves new indication for Gardasil to prevent genital warts in men and boys. Online press release. October 16, 2009. Available at: www.fda.gov/newsevents/newsroom/pressannouncements/ 2009/4cm187003.htm.
34. McPartland TS, Weaver BA, Lee SK, Koutsky LA. Men's perceptions and knowledge of human papillomavirus (HPV) infection and cervical cancer. J Am Coll Health. 2005;53: 225-230.
35. Gerend MA, Barley J. Human papillomavirus vaccine acceptability among young adult men. Sex Transm Dis. 2009;36:58-62.